◆ TICKERBASEOpen interactive view →
◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY
Home › All stocks › T › THEMISMED

Themis Medicare Limited (THEMISMED) Financial History

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Drug Manufacturers - Specialty & Generic · DATA UPDATED 2026-09-20

Themis Medicare Limited (THEMISMED) operates in the Drug Manufacturers - Specialty & Generic industry and is headquartered in Mumbai, India with about 1,340 employees. Its market capitalization is roughly ₹12 billion. In the fiscal year ended 2026-03-31, THEMISMED reported ₹3.4B in revenue and ₹11M in net income.

Themis Medicare Limited, together with its subsidiaries, manufactures and sells pharmaceutical products in India and internationally.

Interactive charts & full statements →

THEMISMED Revenue & Earnings History — Annual Income Statement

Income statement2026-03-312025-03-312024-03-312023-03-31
Total Revenue₹3.4B₹4.0B₹3.8B₹3.4B
Gross Profit₹2.1B₹2.7B₹2.4B₹2.2B
Operating Income (EBIT)(₹99M)₹392M₹393M₹570M
Net Income₹11M₹298M₹435M₹569M

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

THEMISMED Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement2026-06-302026-03-312025-12-312025-09-302025-06-30
Total Revenue₹870M₹765M₹901M₹780M₹976M
Gross Profit₹290M₹528M₹610M₹538M₹452M
Operating Income (EBIT)(₹550M)₹12M₹72M(₹57M)(₹126M)
Net Income₹246M₹89M₹101M(₹36M)(₹142M)

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

THEMISMED Free Cash Flow History

Cash flow2026-03-312025-03-312024-03-312023-03-312022-03-31
Dividends Paid(₹46M)(₹46M)(₹46M)(₹46M)—

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

THEMISMED Balance Sheet History

Balance sheet2026-03-312025-03-312024-03-312023-03-312022-03-31
Total Assets₹6.0B₹5.9B₹5.7B₹5.1B—
Total Liabilities₹2.0B₹1.9B₹1.9B₹1.7B—

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive THEMISMED viewer.

Other Companies in Drug Manufacturers - Specialty & Generic

← THELEELAAll “T” companiesTHEO →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.